Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

922 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.
van 't Hof AW, Ernst N, de Boer MJ, de Winter R, Boersma E, Bunt T, Petronio S, Marcel Gosselink AT, Jap W, Hollak F, Hoorntje JC, Suryapranata H, Dambrink JH, Zijlstra F; On-TIME study group. van 't Hof AW, et al. Among authors: zijlstra f. Eur Heart J. 2004 May;25(10):837-46. doi: 10.1016/j.ehj.2004.04.003. Eur Heart J. 2004. PMID: 15140531 Clinical Trial.
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ; HEBE investigators. Hirsch A, et al. Among authors: zijlstra f. Am Heart J. 2006 Sep;152(3):434-41. doi: 10.1016/j.ahj.2006.02.007. Am Heart J. 2006. PMID: 16923409
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F; Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group. Timmer JR, et al. Among authors: zijlstra f. Arch Intern Med. 2007 Jul 9;167(13):1353-9. doi: 10.1001/archinte.167.13.1353. Arch Intern Med. 2007. PMID: 17620527 Clinical Trial.
Primary percutaneous coronary intervention for ST-elevation myocardial infarction: from clinical trial to clinical practice.
Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Zijlstra F, Suryapranata H, van 't Hof AW; Zwolle Myocardial Infarction Study Group. Rasoul S, et al. Among authors: zijlstra f. Int J Cardiol. 2009 May 1;134(1):104-9. doi: 10.1016/j.ijcard.2008.01.041. Epub 2008 May 27. Int J Cardiol. 2009. PMID: 18502522
Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review.
Vlaar PJ, Svilaas T, Damman K, de Smet BJ, Tijssen JG, Hillege HL, Zijlstra F. Vlaar PJ, et al. Among authors: zijlstra f. Circulation. 2008 Oct 28;118(18):1828-36. doi: 10.1161/CIRCULATIONAHA.107.749531. Epub 2008 Oct 13. Circulation. 2008. PMID: 18852370 Review.
922 results